Effect of secretin on basal- and glucose-stimulated insulin secretion in man. 1978

J Fahrenkrug, and O B Schaffalitzky de Muckadell, and C Kühl

Plasma immunoreactive secretin and insulin concentrations were measured in fasting normal humans after intraduodenal infusions of hydrochloric acid, isotonic or hypertonic glucose. The effect of intraduodenal acidification or intravenous bolus injections of secretin on plasma insulin concentrations during infusions of glucose was also examined. The intraduodenal glucose load did not cause an increase in plasma secretin concentrations. Secretin concentrations rose after acid both in the fasting state and during infusions of glucose. A concomitant rise in insulin levels was however only observed during infusions of glucose. Intravenous injection of secretin in a dose which mimicked the response to intraduodenal acidification was without effect on the glucose-stimulated insulin release, while a 30 times higher dose caused a highly significant augmentation of the insulin release. The insulin response pattern to this high dose of secretin differed completely from that observed after intraduodenal infusion of acid. It is concluded and confirmed that the stimulating effect of secretin on insulin secretion is pharmacological and that secretin plays no significant role in the entero-insular axis.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J Fahrenkrug, and O B Schaffalitzky de Muckadell, and C Kühl
February 1974, Endocrinologia japonica,
J Fahrenkrug, and O B Schaffalitzky de Muckadell, and C Kühl
June 1973, The Journal of clinical investigation,
J Fahrenkrug, and O B Schaffalitzky de Muckadell, and C Kühl
May 1974, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
J Fahrenkrug, and O B Schaffalitzky de Muckadell, and C Kühl
January 1972, Digestion,
J Fahrenkrug, and O B Schaffalitzky de Muckadell, and C Kühl
March 1976, International journal of clinical pharmacology and biopharmacy,
J Fahrenkrug, and O B Schaffalitzky de Muckadell, and C Kühl
February 1978, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
J Fahrenkrug, and O B Schaffalitzky de Muckadell, and C Kühl
July 1970, Gastroenterology,
J Fahrenkrug, and O B Schaffalitzky de Muckadell, and C Kühl
January 1999, Life sciences,
J Fahrenkrug, and O B Schaffalitzky de Muckadell, and C Kühl
February 1978, European journal of clinical investigation,
J Fahrenkrug, and O B Schaffalitzky de Muckadell, and C Kühl
April 1999, Pancreas,
Copied contents to your clipboard!